EPS Forward Acceleration — US Stocks with Rising Analyst Earnings Estimates
Stocks where consensus forward EPS estimates are being revised upward — the most direct signal that professional analysts expect accelerating earnings in the next 12 months.
About This Screen
When professional analysts raise their forward earnings estimates, it reflects new information — better-than-expected recent results, positive management guidance, improved sector outlook, or the recognition that prior estimates were too conservative. Stocks with upward-revised forward EPS estimates have the wind of professional institutional research at their backs, as the same institutions that revise estimates often then add to their positions. This is one of the most actionable institutional signals available.
WHAT THIS SCREEN FINDS: US NYSE and NASDAQ stocks where the consensus forward EPS estimate (next 12 months) has been revised upward — a positive earnings revision signal. Combined with positive current EPS (profitable business), ROE above 10% (quality), and market cap above $500M (institutional quality).
KEY METRICS EXPLAINED: Forward EPS is the consensus average of all analyst earnings per share estimates for the next 12 months. When this consensus estimate rises — even modestly — it reflects analysts incorporating positive new information into their models. The revision direction (up or down) is often more predictive of near-term price performance than the absolute level of the estimate.
WHY INVESTORS USE IT: The earnings revision effect is one of the most empirically robust short-term return signals in academic finance. Stocks with upward earnings revisions significantly outperform in the subsequent 3-6 months, on average. The mechanism: analysts who raise estimates often also raise their price targets and upgrade recommendations — triggering institutional buying from funds tracking analyst changes. Upward revisions create positive momentum that is self-reinforcing.
BENEFITS: Empirically validated earnings revision effect in academic literature. Real-time reflection of professional analyst view changes. Combines forward earnings intelligence with current profitability quality. Particularly powerful near earnings season when estimates are revised most actively. Quality filters prevent speculative revision plays in loss-making companies.
RISKS AND LIMITATIONS: Earnings revisions can be wrong — analysts are imperfect forecasters. Stocks with very large upward revisions may have already moved significantly before the revision is visible. Revision data has a lag — the estimate was revised in the past, and the stock may have already responded. Single-year forward estimates are subject to revision in either direction.
HOW TO ANALYZE STOCKS FROM THIS SCREEN: Check the magnitude of the revision — a 5% upward revision is more significant than 0.5%. Review the reason for the revision: was it a recent earnings beat, new contract win, or improved guidance? Compare forward P/E to historical to assess whether the revised earnings are already priced in. Check if multiple analysts revised, not just one outlier.
COMMON MISTAKES: Buying after the stock has already moved on the revision. Treating small revisions (0.1-0.5%) as equally significant to large ones (5%+). Ignoring the context — sometimes upward revisions reflect lowering the bar rather than genuine outperformance. Not checking if revisions are concentrated in a single outlier analyst or represent broad consensus movement.
Related screens: Bull Cartel (confirmed earnings momentum in actual results), Strong Buy Analyst Consensus (analyst recommendation momentum), Undervalued vs Analyst Target (price target gap), Forward PE Compression (valuation improvement alongside earnings revisions), CANSLIM Growth (earnings acceleration methodology).
Frequently Asked Questions
What is EPS forward acceleration?
EPS forward acceleration occurs when consensus analyst earnings estimates for the next 12 months are revised upward. It means the professional investment community is increasing its expectations for future earnings — reflecting new positive information about the business, sector, or macro environment. Upward earnings revisions are one of the most reliable short-term return signals in equity markets.
Why do upward earnings revisions predict positive stock performance?
When analysts raise estimates, they typically also raise price targets and often upgrade recommendations. This triggers: institutional investors (who track analyst changes) increasing their positions, algorithmic momentum models flagging the positive revision, and retail investors following the upgraded recommendation. The combined buying pressure from these signals creates sustained upward price momentum in the 3-6 months following an upward revision.
What is the earnings revision effect?
The earnings revision effect is the documented tendency for stocks with upward earnings estimate revisions to outperform in subsequent periods, and stocks with downward revisions to underperform. Academic studies (Elgers, Lo, Pfeiffer 2001; Jegadeesh et al. 2004) confirmed significant alpha from following upward revision signals. The effect is strongest in the 3-month period immediately following the revision.
How is consensus forward EPS calculated?
Consensus forward EPS is the arithmetic mean (or sometimes median) of all published analyst estimates for the company's earnings per share over the next 12 months. Financial data providers collect estimates from all major sell-side analysts, aggregate them into a consensus, and update continuously as analysts publish revised estimates. When more analysts revise upward than downward, the consensus figure rises.
How long does the earnings revision effect last?
Academic research suggests the strongest effect is in the 1-3 months following a significant upward revision. The 3-6 month window captures most of the excess return from the revision signal. Beyond 6 months, the effect fades as the new consensus is widely known and the re-rating is mostly complete. For this reason, earnings revision signals are most relevant for medium-term (3-12 month) tactical positions rather than long-term value holdings.
Is a small upward revision (0.5%) as significant as a large one (5%+)?
No. Revision magnitude matters. A 5%+ upward revision reflects meaningful new positive information about future earnings. A 0.5% revision may reflect minor rounding adjustments or one analyst's incremental model tweak. The most powerful revision signals are large revisions (above 3-5%) happening simultaneously across multiple analysts — confirming new, material positive information rather than noise.
What causes analysts to raise earnings estimates?
Most commonly: a recent earnings beat with raised forward guidance (most powerful signal), a new large contract or customer announcement, an analyst initiation with above-consensus estimates, positive sector data releases, M&A activity improving profitability, or raw material cost reductions flowing through to margins. The most durable revisions come from genuine business improvement rather than macro tailwinds.
Can upward revisions be misleading?
Sometimes. If analysts were previously overly pessimistic (too low estimates), an upward revision to still-below-prior-consensus levels can appear bullish while the stock is actually being downgraded versus prior expectations. Context matters: compare the revised estimate to both the prior estimate AND the estimate from 6-12 months ago. Genuine positive revision confirms a higher trajectory, not just catching up from overly cautious prior estimates.
Should I combine forward EPS acceleration with other signals?
Yes. The strongest conviction occurs when: (1) forward EPS estimates are rising (this screen), (2) actual recent earnings have beaten estimates (Bull Cartel screen confirms), (3) the stock is in a Stage 2 uptrend (Minervini Trend Template), and (4) institutional investors are adding to positions (institutional ownership screen). Multiple confirming signals from independent analytical sources create the highest-conviction setups.
How does this screen differ from the Strong Buy Analyst Consensus screen?
EPS Forward Acceleration focuses specifically on the direction of estimate revision — are earnings estimates going up? Strong Buy Analyst Consensus focuses on the recommendation level — do analysts collectively recommend buying the stock? Both are analyst-derived signals, but one captures estimate momentum and the other captures recommendation conviction. Stocks with both upward revisions AND strong buy consensus combine both forms of analyst bullishness.
Results 5 stocks matched
Refreshed daily · Sorted by Market Cap (High → Low)
| S.No. | Company | EPS This Year | EPS Next Year | Fwd EPS Growth % | Forward P/E | Price | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | 52W High | 52W Low |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | YPF Sociedad Anónima | 3.69 | 5.59 | 51.56% | 7.74 | $53.5 | — | $21.35 B | — | — | -7.05% | $60.47 | $24.63 |
| 2. | AstraZeneca PLC | 6.79 | 8.71 | 28.4% | 21.22 | $185.95 | 27.26 | $281.02 B | 0.02% | — | 22.27% | $21,029.41 | $13,508.02 |
| 3. | Greif, Inc. | 5.5 | 7.01 | 27.45% | 11.4 | $79.88 | 22.01 | $3.03 B | 0.04% | — | — | $93.33 | $57.63 |
| 4. | Compañía Cervecerías Unidas S.A. | 0.77 | 0.89 | 15.8% | 13.46 | $11.03 | 16.54 | $2.09 B | 0.02% | — | 7.53% | $7.37 | $5.53 |
| 5. | HDFC Bank Limited | 1.27 | 1.47 | 15.69% | 17.4 | $23.41 | 15.28 | $122.02 B | 0.01% | — | 13.6% | $1,020.5 | $726.65 |